Use of surfactant-based amorphous solid dispersions for BDDCS class II drugs to enhance oral bioavailability: A case report of resveratrol.
Int J Pharm
; 641: 123059, 2023 Jun 25.
Article
in En
| MEDLINE
| ID: mdl-37196879
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Surface-Active Agents
/
Pulmonary Surfactants
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Int J Pharm
Year:
2023
Document type:
Article
Affiliation country:
China